Literature DB >> 18475139

The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome.

Peter M Nilsson1, Empar Lurbe, Stéphane Laurent.   

Abstract

Early vascular ageing is common in patients with hypertension and increased burden of cardiovascular risk factors, often influenced by chronic inflammation. One aspect of this vascular ageing is arterial stiffening, as measured by increased pulse wave velocity or augmentation index and central pressure. Several studies have indicated that this process starts early in life and that arterial function and ageing properties could be programmed during foetal life or influenced by adverse growth patterns in early postnatal life. This could explain the repeated findings in observational epidemiology that an inverse association exists between birth weight, adjusted for gestational age, and systolic blood pressure elevation in childhood, adolescence and adulthood, as well as for increased cardiovascular risk. One new marker of increased pulse pressure and arterial ageing is telomere length, as regulated by telomerase enzymatic activity. Future studies will hopefully shed light on the possibilities to halt or even reverse vascular ageing, and thereby also influence telomere biology and its different expressions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18475139     DOI: 10.1097/HJH.0b013e3282f82c3e

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  48 in total

Review 1.  Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge.

Authors:  Angelo Scuteri; Edward G Lakatta
Journal:  Exp Gerontol       Date:  2012-03-03       Impact factor: 4.032

2.  Stopping the cardiovascular disease continuum: Focus on prevention.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2010-03-26

3.  Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes.

Authors:  Raija Lithovius; Daniel Gordin; Carol Forsblom; Markku Saraheimo; Valma Harjutsalo; Per-Henrik Groop
Journal:  Diabetologia       Date:  2018-05-24       Impact factor: 10.122

Review 4.  How to Measure Arterial Stiffness in Humans.

Authors:  Patrick Segers; Ernst R Rietzschel; Julio A Chirinos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-26       Impact factor: 8.311

5.  Aortic pulse wave velocity in individuals of Asian and African ancestry: the HELISUR study.

Authors:  Frederieke S Diemer; Se-Sergio M Baldew; Yentl C Haan; Fares A Karamat; Glenn P Oehlers; Gert A van Montfrans; Bert-Jan H van den Born; Ron J G Peters; Lenny M W Nahar-Van Venrooij; Lizzy M Brewster
Journal:  J Hum Hypertens       Date:  2018-12-19       Impact factor: 3.012

Review 6.  Early vascular phenotypes in the genesis of hypertension.

Authors:  Empar Lurbe; Maria Isabel Torró
Journal:  Pediatr Nephrol       Date:  2010-04       Impact factor: 3.714

7.  A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention.

Authors:  S G Chrysant
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

8.  Impact of the AGTR1 A1166C polymorphism on subcortical hyperintensities and cognition in healthy older adults.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Thomas E Conturo; David F Tate; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Erbil Akbudak; Robert H Paul
Journal:  Age (Dordr)       Date:  2014-07-01

9.  Thoracic and abdominal aortas stiffen through unique extracellular matrix changes in intrauterine growth restricted fetal sheep.

Authors:  R Blair Dodson; Paul J Rozance; Carson C Petrash; Kendall S Hunter; Virginia L Ferguson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

Review 10.  Hypertension and diabetes: should we treat early surrogates? What are the cons?

Authors:  Peter M Nilsson
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.